FLI1 and Cognitive impairment: The inhibition of Fli-1 via antisense oligonucleotide Fli-1 Gapmer decelerates pericyte loss, reduces inflammatory response, ameliorates cognitive deficits, improves BBB function, and decreases Aβ deposition [7].